Trifluoroibuprofen inhibits a-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models. (2014)

First Author: Festuccia C
Attributed to:  Core Capability for Chemistry Research at the University of Liverpool funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2174/1871520614666140327152607

PubMed Identifier: 24712326

Publication URI: http://europepmc.org/abstract/MED/24712326

Type: Journal Article/Review

Volume: 14

Parent Publication: Anti-cancer agents in medicinal chemistry

Issue: 7

ISSN: 1871-5206